AASS anticorps (AA 220-300)

N° du produit ABIN7213406

Cet anticorps Lapin Polyclonal détecte spécifiquement AASS dans WB et ELISA. Il présente une réactivité avec des échantillons de Humain, Souris et Rat.

Aperçu rapide pour AASS anticorps (AA 220-300) (ABIN7213406)

Antigène: AASS (Aminoadipate Semialdehyde Synthase (AASS))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AASS est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-AASS anticorps

Épitope: AA 220-300

Fonction: Rabbit Anti-AASS Polyclonal Antibody

Specificité: AASS Polyclonal Antibody detects endogenous levels of AASS protein.

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogène: Synthesized peptide derived from the Internal region of human AASS at AA range: 220-300

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,ELISA 1:10000,Not yet tested in other applications.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Date de péremption: 12 months

Détails sur AASS

Antigène: AASS (Aminoadipate Semialdehyde Synthase (AASS))

Autre désignation: AASS

Sujet: AASS, Alpha-aminoadipic semialdehyde synthase, mitochondrial, LKR/SDHAASS encodes a bifunctional enzyme (aminoadipate-semialdehyde synthase) that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in AASS are associated with familial hyperlysinemia.

Poids moléculaire: 102kD

ID gène: 10157

UniProt: Q9UDR5

Pathways: SARS-CoV-2 Protein Interactome